Looking at the present situationCovid case rise in the US means strong demand for BOS products. The probability of the second tranche of the $576M deal to kick in. We may hear about that sooner than later this year considering there are less than 5 months left.
"HHS has provided ADG authorization to proceed immediately on an initial order expected to be worth up to US$288 million, with an equivalent follow-on option which HHS may exercise later in 2021 for an additional US$288 million."
Remember earning out today after market close. I anticipate growth and either increase in dividend or a special dividend (cash or shares). This all my opinion,hopes and dreams and not financial advice.